Cargando…

Clinical and Molecular Correlates of Abnormal Changes in the Cerebellum and Globus Pallidus in Fragile X Premutation

BACKGROUND: Fragile X premutation carriers (55–200 CGG triplets) may develop a progressive neurodegenerative disorder, fragile X-associated tremor/ataxia syndrome (FXTAS), after the age of 50. The neuroradiologic markers of FXTAS are hyperintense T2-signals in the middle cerebellar peduncle—the MCP...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jun Yi, Grigsby, Jim, Placido, Diego, Wei, Hongjiang, Tassone, Flora, Kim, Kyoungmi, Hessl, David, Rivera, Susan M., Hagerman, Randi J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863211/
https://www.ncbi.nlm.nih.gov/pubmed/35211082
http://dx.doi.org/10.3389/fneur.2022.797649
_version_ 1784655189066645504
author Wang, Jun Yi
Grigsby, Jim
Placido, Diego
Wei, Hongjiang
Tassone, Flora
Kim, Kyoungmi
Hessl, David
Rivera, Susan M.
Hagerman, Randi J.
author_facet Wang, Jun Yi
Grigsby, Jim
Placido, Diego
Wei, Hongjiang
Tassone, Flora
Kim, Kyoungmi
Hessl, David
Rivera, Susan M.
Hagerman, Randi J.
author_sort Wang, Jun Yi
collection PubMed
description BACKGROUND: Fragile X premutation carriers (55–200 CGG triplets) may develop a progressive neurodegenerative disorder, fragile X-associated tremor/ataxia syndrome (FXTAS), after the age of 50. The neuroradiologic markers of FXTAS are hyperintense T2-signals in the middle cerebellar peduncle—the MCP sign. We recently noticed abnormal T2-signals in the globus pallidus in male premutation carriers and controls but the prevalence and clinical significance were unknown. METHODS: We estimated the prevalence of the MCP sign and pallidal T2-abnormalities in 230 male premutation carriers and 144 controls (aged 8–86), and examined the associations with FXTAS symptoms, CGG repeat length, and iron content in the cerebellar dentate nucleus and globus pallidus. RESULTS: Among participants aged ≥45 years (175 premutation carriers and 82 controls), MCP sign was observed only in premutation carriers (52 vs. 0%) whereas the prevalence of pallidal T2-abnormalities approached significance in premutation carriers compared with controls after age-adjustment (25.1 vs. 13.4%, p = 0.069). MCP sign was associated with impaired motor and executive functioning, and the additional presence of pallidal T2-abnormalities was associated with greater impaired executive functioning. Among premutation carriers, significant iron accumulation was observed in the dentate nucleus, and neither pallidal or MCP T2-abnormalities affected measures of the dentate nucleus. While the MCP sign was associated with CGG repeat length >75 and dentate nucleus volume correlated negatively with CGG repeat length, pallidal T2-abnormalities did not correlate with CGG repeat length. However, pallidal signal changes were associated with age-related accelerated iron depletion and variability and having both MCP and pallidal signs further increased iron variability in the globus pallidus. CONCLUSIONS: Only the MCP sign, not pallidal abnormalities, revealed independent associations with motor and cognitive impairment; however, the occurrence of combined MCP and pallidal T2-abnormalities may present a risk for greater cognitive impairment and increased iron variability in the globus pallidus.
format Online
Article
Text
id pubmed-8863211
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88632112022-02-23 Clinical and Molecular Correlates of Abnormal Changes in the Cerebellum and Globus Pallidus in Fragile X Premutation Wang, Jun Yi Grigsby, Jim Placido, Diego Wei, Hongjiang Tassone, Flora Kim, Kyoungmi Hessl, David Rivera, Susan M. Hagerman, Randi J. Front Neurol Neurology BACKGROUND: Fragile X premutation carriers (55–200 CGG triplets) may develop a progressive neurodegenerative disorder, fragile X-associated tremor/ataxia syndrome (FXTAS), after the age of 50. The neuroradiologic markers of FXTAS are hyperintense T2-signals in the middle cerebellar peduncle—the MCP sign. We recently noticed abnormal T2-signals in the globus pallidus in male premutation carriers and controls but the prevalence and clinical significance were unknown. METHODS: We estimated the prevalence of the MCP sign and pallidal T2-abnormalities in 230 male premutation carriers and 144 controls (aged 8–86), and examined the associations with FXTAS symptoms, CGG repeat length, and iron content in the cerebellar dentate nucleus and globus pallidus. RESULTS: Among participants aged ≥45 years (175 premutation carriers and 82 controls), MCP sign was observed only in premutation carriers (52 vs. 0%) whereas the prevalence of pallidal T2-abnormalities approached significance in premutation carriers compared with controls after age-adjustment (25.1 vs. 13.4%, p = 0.069). MCP sign was associated with impaired motor and executive functioning, and the additional presence of pallidal T2-abnormalities was associated with greater impaired executive functioning. Among premutation carriers, significant iron accumulation was observed in the dentate nucleus, and neither pallidal or MCP T2-abnormalities affected measures of the dentate nucleus. While the MCP sign was associated with CGG repeat length >75 and dentate nucleus volume correlated negatively with CGG repeat length, pallidal T2-abnormalities did not correlate with CGG repeat length. However, pallidal signal changes were associated with age-related accelerated iron depletion and variability and having both MCP and pallidal signs further increased iron variability in the globus pallidus. CONCLUSIONS: Only the MCP sign, not pallidal abnormalities, revealed independent associations with motor and cognitive impairment; however, the occurrence of combined MCP and pallidal T2-abnormalities may present a risk for greater cognitive impairment and increased iron variability in the globus pallidus. Frontiers Media S.A. 2022-02-08 /pmc/articles/PMC8863211/ /pubmed/35211082 http://dx.doi.org/10.3389/fneur.2022.797649 Text en Copyright © 2022 Wang, Grigsby, Placido, Wei, Tassone, Kim, Hessl, Rivera and Hagerman. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Wang, Jun Yi
Grigsby, Jim
Placido, Diego
Wei, Hongjiang
Tassone, Flora
Kim, Kyoungmi
Hessl, David
Rivera, Susan M.
Hagerman, Randi J.
Clinical and Molecular Correlates of Abnormal Changes in the Cerebellum and Globus Pallidus in Fragile X Premutation
title Clinical and Molecular Correlates of Abnormal Changes in the Cerebellum and Globus Pallidus in Fragile X Premutation
title_full Clinical and Molecular Correlates of Abnormal Changes in the Cerebellum and Globus Pallidus in Fragile X Premutation
title_fullStr Clinical and Molecular Correlates of Abnormal Changes in the Cerebellum and Globus Pallidus in Fragile X Premutation
title_full_unstemmed Clinical and Molecular Correlates of Abnormal Changes in the Cerebellum and Globus Pallidus in Fragile X Premutation
title_short Clinical and Molecular Correlates of Abnormal Changes in the Cerebellum and Globus Pallidus in Fragile X Premutation
title_sort clinical and molecular correlates of abnormal changes in the cerebellum and globus pallidus in fragile x premutation
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863211/
https://www.ncbi.nlm.nih.gov/pubmed/35211082
http://dx.doi.org/10.3389/fneur.2022.797649
work_keys_str_mv AT wangjunyi clinicalandmolecularcorrelatesofabnormalchangesinthecerebellumandglobuspallidusinfragilexpremutation
AT grigsbyjim clinicalandmolecularcorrelatesofabnormalchangesinthecerebellumandglobuspallidusinfragilexpremutation
AT placidodiego clinicalandmolecularcorrelatesofabnormalchangesinthecerebellumandglobuspallidusinfragilexpremutation
AT weihongjiang clinicalandmolecularcorrelatesofabnormalchangesinthecerebellumandglobuspallidusinfragilexpremutation
AT tassoneflora clinicalandmolecularcorrelatesofabnormalchangesinthecerebellumandglobuspallidusinfragilexpremutation
AT kimkyoungmi clinicalandmolecularcorrelatesofabnormalchangesinthecerebellumandglobuspallidusinfragilexpremutation
AT hessldavid clinicalandmolecularcorrelatesofabnormalchangesinthecerebellumandglobuspallidusinfragilexpremutation
AT riverasusanm clinicalandmolecularcorrelatesofabnormalchangesinthecerebellumandglobuspallidusinfragilexpremutation
AT hagermanrandij clinicalandmolecularcorrelatesofabnormalchangesinthecerebellumandglobuspallidusinfragilexpremutation